Creo Medical Group PLC (AIM:CREO) has released a patient testimonial highlighting its Speedboat technology, after Liz Thomas avoided major bowel surgery by undergoing a minimally invasive procedure that used the device.
Previously unavailable through NHS Wales, Liz accessed the treatment privately in England and recovered within days.
The case underlines Speedboat’s clinical value for early colorectal cancer, allowing removal of pre-cancerous lesions without major surgery. The technology is being piloted in Wales by Aneurin Bevan University Health Board. Click here for the video.